Literature DB >> 11246689

Discrimination of changes in osteoporosis outcomes.

A Cranney1, V Welch, G Wells, J Adachi, B Shea, L Simon, P Tugwell.   

Abstract

The purpose of this paper was to identify existing work related to discrimination, responsiveness, and minimal clinically important differences (MCID) for 4 key clinical outcomes in osteoporosis, to serve as a background to discussions about how to define MCID for both individuals and groups. The outcomes assessed were bone density, fractures, quality of life, and function. We conducted a systematic literature search in MEDLINE, EMBASE, and Current Contents for articles that discussed responsiveness, detectable difference, improvement criteria, and clinical importance. We used the Beaton cube to classify the studies depending on whether they compared differences between or changes within individuals or groups. Although a number of studies were identified that presented data on detectable differences beyond error and observed differences, few studies presented data on how to define clinically important differences. A key priority for future research is to define minimally clinical important differences for clinically important osteoporosis outcomes using a consensus based approach that will be accepted by the osteoporosis community at large. Furthermore, these MCID will likely be different for individual patients seen in clinical practice than for individuals in a clinical trial.

Entities:  

Mesh:

Year:  2001        PMID: 11246689

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

1.  Quality-of-life assessment in osteoporosis: health-status and preference-based measures.

Authors:  Anna N A Tosteson; Cristina S Hammond
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 2.  Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic review.

Authors:  Jenni Hislop; Temitope E Adewuyi; Luke D Vale; Kirsten Harrild; Cynthia Fraser; Tara Gurung; Douglas G Altman; Andrew H Briggs; Peter Fayers; Craig R Ramsay; John D Norrie; Ian M Harvey; Brian Buckley; Jonathan A Cook
Journal:  PLoS Med       Date:  2014-05-13       Impact factor: 11.069

3.  Functional outcomes and quality of life after a 6-month early intervention program for oral cancer survivors: a single-arm clinical trial.

Authors:  Yueh-Hsia Chen; Wei-An Liang; Chung-Yin Hsu; Siang-Lan Guo; Shwu-Huei Lien; Hsiao-Jung Tseng; Yuan-Hung Chao
Journal:  PeerJ       Date:  2018-02-21       Impact factor: 2.984

4.  Research response to coronavirus disease 2019 needed better coordination and collaboration: a living mapping of registered trials.

Authors:  Van Thu Nguyen; Philippe Rivière; Pierre Ripoll; Julien Barnier; Romain Vuillemot; Gabriel Ferrand; Sarah Cohen-Boulakia; Philippe Ravaud; Isabelle Boutron
Journal:  J Clin Epidemiol       Date:  2020-10-21       Impact factor: 6.437

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.